Article
Adenovirus-vectored T cell vaccine for hepacivirus shows reduced effectiveness against a CD8 T cell escape variant in rats.
PLoS pathogens - 1 Mar 2021
Hartlage Alex S, Dravid Piyush, Walker Christopher M, Kapoor Amit
Abstract excerpt
There is an urgent need for a vaccine to prevent chronic infection by hepatitis C virus (HCV) and its many genetic variants. The first human vaccine trial, using recombinant viral vectors that stimulate pan-genotypic T cell responses against HCV non-structural proteins, failed to demonstrate efficacy despite significant preclinical promise. Understanding the factors that govern HCV T cell vaccine success is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
